Clinical Trials List
2020-07-01 - 2027-07-31
Phase I
Not yet recruiting1
Recruiting5
ICD-10C18.9
Malignant neoplasm of colon, unspecified
ICD-10C7A.029
Malignant carcinoid tumor of the large intestine, unspecified portion
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.9
Malignant neoplasm of colon, unspecified
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 林季宏 無
- SHIH-HUNG YANG 未分科
- Chih-Hung Hsu 無
- 呂理駿 無
- YEN-SHEN LU 無
- 陳怡君 無
- Ann-Lii Cheng 無
- YU-YUN SHAO 無
- 廖斌志 無
- 張端瑩 無
- Yu-Chieh Tsai 無
- Chiun Hsu 無
- TSUNG-HAO LIU 無
- SHIH-HUNG YANG 無
- Wei-Wu Chen 無
- FU-JEN HSUEH 無
- Ying-Chun Shen 無
- HUAI-CHENG HUANG 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張琮琨 Division of Colorectal Surgery
- Wei-Chih Su Division of Colorectal Surgery
- 黃敬文 Division of Colorectal Surgery
- 蔡祥麟 Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 姜乃榕 無
- Chueh-Chuan Yen 無
- Jiun-I Lai 無
- Ming-Huang Chen 無
- Hao-Wei Teng 無
- Chien-An Liu 無
- Yi-Ping Hung 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林昶廷 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
- 常景棣 Division of Radiology
- 黃詩喻 Division of Hematology & Oncology
- 林偉雄 Division of Radiology
- 陳彥仰 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 沈鼎文 Division of Radiology
- 張境夫 Division of Hematology & Oncology
- 黃亮鋼 Division of Hematology & Oncology
- 吳俊德 Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- 余紹銘 Division of Hematology & Oncology
- PO-HUNG LIN Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
362 participants
